Benjamin R. Cowen
Director/Board Member bij INCON CO.,LTD.
Profiel
Benjamin R.
Cowen is currently the President & Chief Executive Officer at ImmunoMet Therapeutics, Inc. He is also a Director at INCON Co., Ltd.
and has been a Director at Atrin Pharmaceuticals LLC since 2012.
Previously, he served as the Vice President-Corporate Development at Milestone Pharmaceuticals, Inc. Dr. Cowen holds an MBA degree from Carnegie Mellon University, which he obtained in 1997.
He also holds a doctorate degree from the University of Illinois, which he received in 1990.
Actieve functies van Benjamin R. Cowen
Bedrijven | Functie | Begin |
---|---|---|
INCON CO.,LTD. | Director/Board Member | - |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Director/Board Member | 01-01-2012 |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Chief Executive Officer | 01-11-2017 |
Eerdere bekende functies van Benjamin R. Cowen
Bedrijven | Functie | Einde |
---|---|---|
MILESTONE PHARMACEUTICALS INC. | Corporate Officer/Principal | - |
Opleiding van Benjamin R. Cowen
Carnegie Mellon University | Masters Business Admin |
University of Illinois | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MILESTONE PHARMACEUTICALS INC. | Health Technology |
INCON CO.,LTD. | Consumer Durables |
Bedrijven in privébezit | 2 |
---|---|
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Health Technology |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |